Bereich
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment
Sabbioni M, Goldhirsch A, Herrmann R, Perey L, Bonnefoi H, Thürlimann B, Castiglione M, Bernhard J, Bacchi M, Siegrist H, Hürny C. Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment. Breast cancer research and treatment 2000; 59:279-87.
01.02.2000Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment
01.02.2000Breast cancer research and treatment 2000; 59:279-87
Sabbioni M E, Goldhirsch A, Herrmann R, Perey L, Bonnefoi H, Thürlimann Beat, Castiglione M, Bernhard J, Bacchi M, Siegrist H P, Hürny C
Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma. Swiss Group for Clinical Cancer Research (SAKK)
Morant R, Hürny C, Hanselmann S, Zulian G, Bauer J, Trinkler F, Jacky E, Thürlimann B, Fey M, Borner M, Maibach R, Bernhard J, Hering F. Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma. Swiss Group for Clinical Cancer Research (SAKK). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000; 11:183-8.
01.02.2000Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma. Swiss Group for Clinical Cancer Research (SAKK)
01.02.2000Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000; 11:183-8
Morant R, Hürny C, Hanselmann S, Zulian G, Bauer J, Trinkler F, Jacky E, Thürlimann Beat, Fey M F, Borner M, Maibach R, Bernhard J, Hering F
Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group
Colleoni M, Marini G, Veronesi A, Holmberg S, Thürlimann B, Collins J, Lindtner J, Rudenstam C, Price K, Gelber R, Castiglione-Gertsch M, Coates A, Bonetti M, Goldhirsch A. Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000; 18:584-90.
01.02.2000Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group
01.02.2000Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000; 18:584-90
Colleoni M, Marini G, Veronesi A, Holmberg S, Thürlimann Beat, Collins J, Lindtner J, Rudenstam C M, Price K, Gelber R D, Castiglione-Gertsch M, Coates A S, Bonetti M, Goldhirsch A
Small-cell lung cancer with brain metastases and survival for more than 15 years despite incomplete therapy
Ruhstaller T, Thürlimann B. Small-cell lung cancer with brain metastases and survival for more than 15 years despite incomplete therapy. Onkologie 2000; 23:64-66.
01.02.2000Small-cell lung cancer with brain metastases and survival for more than 15 years despite incomplete therapy
01.02.2000Onkologie 2000; 23:64-66
Ruhstaller Thomas, Thürlimann Beat
[Oncology 1999: advances in immunotherapy]
Cerny T. [Oncology 1999: advances in immunotherapy]. Schweizerische medizinische Wochenschrift 2000; 130:21-4.
11.01.2000[Oncology 1999: advances in immunotherapy]
11.01.2000Schweizerische medizinische Wochenschrift 2000; 130:21-4
Cerny Thomas
Leben lernen - Sterben lernen
Renz M, Riedel L. Leben lernen - Sterben lernen. In: Dem Wesentlichen auf der Spur. Riehen: Perspectiva, 1999. S. 199-216.
01.01.2000Leben lernen - Sterben lernen
01.01.2000Perspectiva
Renz Monika, Riedel L
Im Angesicht des Todes
Renz M. Im Angesicht des Todes - Sterbebegleitung - eine Aufgabe für PsychologInnen. Psychoscope 2000; 21:15-17.
01.01.2000Im Angesicht des Todes
01.01.2000Psychoscope 2000; 21:15-17
Renz Monika
Die neoadjuvante endokrine Theraphie des Mammakarzinoms
Meyer A, Huober J, Krainick-Strobel U, Greb R, Wagner U, Wallwiener D. Die neoadjuvante endokrine Theraphie des Mammakarzinoms. Onkologe 2000; 1:67-71.
01.01.2000Die neoadjuvante endokrine Theraphie des Mammakarzinoms
01.01.2000Onkologe 2000; 1:67-71
Meyer A, Huober Jens, Krainick-Strobel U, Greb R, Wagner U, Wallwiener D
[Recurrent hyperparathyroidism in kidney failure patients after total parathyroidectomy and autotransplantation. Case report and review of the literature]
Gueller U, Schönholzer C, Martinoli S. [Recurrent hyperparathyroidism in kidney failure patients after total parathyroidectomy and autotransplantation. Case report and review of the literature]. Swiss Surg 2000; 6:179-81.
01.01.2000[Recurrent hyperparathyroidism in kidney failure patients after total parathyroidectomy and autotransplantation. Case report and review of the literature]
01.01.2000Swiss Surg 2000; 6:179-81
Gueller Ulrich, Schönholzer C, Martinoli S
[Importance of lymph node involvement in breast carcinoma for the oncologist]
Cerny T. [Importance of lymph node involvement in breast carcinoma for the oncologist]. Zentralblatt für Chirurgie 2000; 125:813-6.
01.01.2000[Importance of lymph node involvement in breast carcinoma for the oncologist]
01.01.2000Zentralblatt für Chirurgie 2000; 125:813-6
Cerny Thomas
Role of high-dose therapy in diffuse large B-cell lymphoma
Cerny T, Betticher D. Role of high-dose therapy in diffuse large B-cell lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000; 11 Suppl 3:117-21.
01.01.2000Role of high-dose therapy in diffuse large B-cell lymphoma
01.01.2000Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000; 11 Suppl 3:117-21
Cerny Thomas, Betticher D
Pharmacokinetics of 2-chloro-2'-deoxyadenosine administered subcutaneously or by continuous intravenous infusion
Sonderegger T, Betticher D, Cerny T, Lauterburg B. Pharmacokinetics of 2-chloro-2'-deoxyadenosine administered subcutaneously or by continuous intravenous infusion. Cancer chemotherapy and pharmacology 2000; 46:40-2.
01.01.2000Pharmacokinetics of 2-chloro-2'-deoxyadenosine administered subcutaneously or by continuous intravenous infusion
01.01.2000Cancer chemotherapy and pharmacology 2000; 46:40-2
Sonderegger T, Betticher D C, Cerny Thomas, Lauterburg B H
Analgesic action of i.v. morphine-6-glucuronide in healthy volunteers
Buetler T, Wilder-Smith O, Wilder-Smith C, Aebi S, Cerny T, Brenneisen R. Analgesic action of i.v. morphine-6-glucuronide in healthy volunteers. British journal of anaesthesia 2000; 84:97-9.
01.01.2000Analgesic action of i.v. morphine-6-glucuronide in healthy volunteers
01.01.2000British journal of anaesthesia 2000; 84:97-9
Buetler T M, Wilder-Smith O H, Wilder-Smith C H, Aebi S, Cerny Thomas, Brenneisen R
The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK)
Ghielmini M, Bertoni F, Schmitter D, Lohri A, Wernli M, Stupp R, Betticher D, Pichert G, Bürki K, Schmitz S, Cerny T. The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000; 11 Suppl 1:123-6.
01.01.2000The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK)
01.01.2000Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000; 11 Suppl 1:123-6
Ghielmini M, Bertoni F, Schmitter D, Lohri A, Wernli M, Stupp R, Betticher D C, Pichert G, Bürki K, Schmitz S F, Cerny Thomas
Photodynamic Therapy of Recurrent Breast Cancer
Hornung R, Wyss P, Fehr M, Schwarz V, Haller U. Photodynamic Therapy of Recurrent Breast Cancer. In: Photomedicine in Gynecology and Reproduction. Freiburg: Karger, 1999. S. 322-325.
01.01.2000Photodynamic Therapy of Recurrent Breast Cancer
01.01.2000Karger
Hornung René, Wyss P, Fehr M., Schwarz Viola A., Haller U
Streptobacillus moniliformis endocarditis in an HIV-positive patient.
Rordorf T, Züger C, Zbinden R, von Graevenitz A, Pirovino M. Streptobacillus moniliformis endocarditis in an HIV-positive patient. Infection 2000; 28:393-4.
01.01.2000Streptobacillus moniliformis endocarditis in an HIV-positive patient.
01.01.2000Infection 2000; 28:393-4
Rordorf Tamara, Züger C, Zbinden R, von Graevenitz A, Pirovino Mauro
Proteases involved in MHC class II antigen presentation
Villadangos J, Peters C, Chapman H, Shi G, Saftig P, Roth W, Riese R, Lennon-Dumenil A, Driessen C, Deussing J, Bryant R, Ploegh H. Proteases involved in MHC class II antigen presentation. Immunological reviews 1999; 172:109-20.
01.12.1999Proteases involved in MHC class II antigen presentation
01.12.1999Immunological reviews 1999; 172:109-20
Villadangos J A, Peters C, Chapman H A, Shi G P, Saftig P, Roth W, Riese R J, Lennon-Dumenil A M, Driessen Christoph, Deussing J, Bryant R A, Ploegh H L
Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells
Driessen C, Bryant R, Lennon-Dumenil A, Villadangos J, Bryant P, Shi G, Chapman H, Ploegh H. Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells. The Journal of cell biology 1999; 147:775-90.
15.11.1999Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells
15.11.1999The Journal of cell biology 1999; 147:775-90
Driessen Christoph, Bryant R A, Lennon-Dumenil A M, Villadangos J A, Bryant P W, Shi G P, Chapman H A, Ploegh H L
Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy
Rizzoli R, Eghbali H, Clemens M, Thürlimann B, Degardin M, Steinhauer E, Tubiana-Hulin M, Manegold C, Rückert F, Huss H, Herrmann Z, Pecherstorfer M, Bundred N, Thiébaud D, Body J. Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy. The Journal of clinical endocrinology and metabolism 1999; 84:3545-50.
01.10.1999Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy
01.10.1999The Journal of clinical endocrinology and metabolism 1999; 84:3545-50
Rizzoli R, Eghbali H, Clemens M R, Thürlimann Beat, Degardin M, Steinhauer E U, Tubiana-Hulin M, Manegold C, Rückert F, Huss H J, Herrmann Z, Pecherstorfer M, Bundred N, Thiébaud D, Body J J
Accelerated progression of multiple myeloma during anti-CD20 (Rituximab) therapy
Korte W, Jost C, Cogliatti S, Hess U, Cerny T. Accelerated progression of multiple myeloma during anti-CD20 (Rituximab) therapy. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999; 10:1249-50.
01.10.1999Accelerated progression of multiple myeloma during anti-CD20 (Rituximab) therapy
01.10.1999Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999; 10:1249-50
Korte W, Jost C, Cogliatti S, Hess U, Cerny Thomas